# Zepbound (tirzepatide): Dosage, Side Effects & Uses

Source: https://pepvault.app/drugs/zepbound

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Brand-name drugs](https://pepvault.app/drugs) Zepbound

Brand-name drug · GIP and GLP-1 receptor agonist

# Zepbound (tirzepatide)

From the FDA label, read Nov 18, 2026 [Published by PepVault](https://pepvault.app/guides/how-we-research)

Zepbound is tirzepatide from Eli Lilly, a weekly injection that targets both the GIP and GLP-1 receptors.

Alongside a reduced-calorie diet and more physical activity, FDA approved it to reduce excess weight and keep it off in adults with obesity, or with overweight and a weight-related condition, and to treat moderate to severe obstructive sleep apnea in adults with obesity.

- **Active ingredient:** [Tirzepatide](https://pepvault.app/peptides/tirzepatide)
- **Maker:** Eli Lilly
- **Class:** GIP and GLP-1 receptor agonist
- **FDA application:** [NDA 217806](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217806), first approved 2023

## What FDA approved it for

The label advises against combining Zepbound with any other tirzepatide product, such as Mounjaro, or with any GLP-1 medicine.

From the label: 1 Indications and Usage.

## How it is supplied

Zepbound’s forms and the doses each one gives, as the label lists them

| Form | Doses |
| --- | --- |
| Single-dose pen or vial | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |
| Multi-dose vial or KwikPen (4 doses) | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |

From the label: 3 Dosage Forms and Strengths.

## The label’s dosing schedule

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

### Zepbound, once a week

Zepbound’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Zepbound, once a week: the steps on the label. Highest dose: 15 mg a week.

| Dose | When, on the label |
| --- | --- |
| 2.5 mg a week | The first 4 weeks (starting step only) |
| 5 mg a week | After the first 4 weeks |
| 7.5 mg a week | After at least 4 weeks, if needed |
| 10 mg a week | After at least 4 weeks, if needed |
| 12.5 mg a week | After at least 4 weeks, if needed |
| 15 mg a week | Maximum for all uses |

For weight, the label’s lasting dose is 5 mg, 10 mg or 15 mg a week; for sleep apnea it is 10 mg or 15 mg. The maximum for every use is 15 mg.

The 2.5 mg month is only a start and is not approved to stay on. If someone doesn’t tolerate a lasting dose, the label suggests a lower one.

From the label: 2.1 Recommended Dose Escalation Schedule; 2.2 Recommended Maintenance and Maximum Dosage; 2.2 Recommended Maintenance and Maximum Dosage; 2.1 Recommended Dose Escalation Schedule.

## How it’s taken

One injection a week, any time of day and with or without food, under the skin of the belly or thigh; another person can inject it into the back of the upper arm. The spot changes with each dose, and Zepbound is used together with diet and activity.

Zepbound comes as a single-dose pen, a single-dose vial, a multi-dose vial and a KwikPen; the multi-dose vial and the KwikPen each hold 4 doses.

People with poor eyesight should not inject themselves with the KwikPen, the label says.

From the label: 2.4 Important Administration Instructions; 3 Dosage Forms and Strengths.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## If a dose is missed

Zepbound’s missed-dose rule gives 4 days (96 hours): within that window the dose is taken as soon as possible; after it, the dose is skipped and the week carries on as usual.

Moving the injection day is fine when two doses stay at least 3 days (72 hours) apart.

From the label: 2.3 Recommendations Regarding Missed Dose.

## Storage

Zepbound pens and vials go in the fridge at 36°F to 46°F and are never frozen. A single-dose pen or vial may be kept out of the fridge, up to 86°F, for 21 days in total, then thrown away.

An unopened KwikPen or multi-dose vial is good to its expiry date in the fridge; kept at room temperature, it is discarded after 30 days.

From the label: 16.2 Storage and Handling.

## Side effects and warnings

Adverse reactions in at least 2% of adults on Zepbound and more often than on placebo, two weight trials (first ten rows). Percent of people.

| Reaction | Placebo | 5 mg | 10 mg | 15 mg |
| --- | --- | --- | --- | --- |
| Nausea | 8 | 25 | 29 | 28 |
| Diarrhea | 8 | 19 | 21 | 23 |
| Vomiting | 2 | 8 | 11 | 13 |
| Constipation | 5 | 17 | 14 | 11 |
| Abdominal pain | 5 | 9 | 9 | 10 |
| Dyspepsia | 4 | 9 | 9 | 10 |
| Injection site reactions | 2 | 6 | 8 | 8 |
| Fatigue | 3 | 5 | 6 | 7 |
| Hypersensitivity reactions | 3 | 5 | 5 | 5 |
| Eructation (burping) | 1 | 4 | 5 | 5 |

Across the two trials, 4.8%, 6.3% and 6.7% of people on 5 mg, 10 mg and 15 mg stopped because of side effects, against 3.4% on placebo.

### The boxed warning

**Boxed warning: “RISK OF THYROID C-CELL TUMORS”**Zepbound carries a boxed warning on thyroid C-cell tumors seen in rats given tirzepatide; the label says it is unknown whether this happens in people. It is not for anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2.

### The other warnings

Its warnings list starts with severe stomach side effects and goes on to kidney injury from fluid loss, gallbladder disease, pancreatitis, allergic reactions, low blood sugar, diabetic eye changes in type 2 diabetes and aspiration under anesthesia; a KwikPen is never shared.

From the label: 6.1 Clinical Trials Experience; Boxed Warning; 5 Warnings and Precautions.

## How Zepbound differs from Mounjaro

Zepbound and Mounjaro hold the same active ingredient, tirzepatide. What sets them apart is on their labels: what each is approved for, the forms it comes in and how high its schedule goes.

Tirzepatide brands, label against label

| Compared | [Zepbound](https://pepvault.app/drugs/zepbound) | [Mounjaro](https://pepvault.app/drugs/mounjaro) |
| --- | --- | --- |
| Approved for | Weight reduction; obstructive sleep apnea with obesity | Type 2 diabetes (adults and children 10 and up); heart risk |
| Forms | Single-dose pen or vial; Multi-dose vial or KwikPen | Single-dose pen or vial; Multi-dose vial or KwikPen |
| Label’s dose range | 2.5 mg to 15 mg once a week | 2.5 mg to 15 mg once a week |
| Top dose | 15 mg a week | 15 mg a week |
| Maker | Eli Lilly | Eli Lilly |

[Mounjaro vs Zepbound: the two labels side by side](https://pepvault.app/drugs/compare/mounjaro-vs-zepbound)

## What else we have on tirzepatide

### Tirzepatide on PepVault

- [Tirzepatide in the peptide library](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide: half-life](https://pepvault.app/peptides/tirzepatide/half-life)
- [Tirzepatide: side effects](https://pepvault.app/peptides/tirzepatide/side-effects)
- [Tirzepatide: how long it takes to work](https://pepvault.app/peptides/tirzepatide/how-long-to-work)
- [Tirzepatide: what it’s stacked with](https://pepvault.app/peptides/tirzepatide/stacks)
- [Is Tirzepatide legal? FDA, DEA and WADA status](https://pepvault.app/peptides/tirzepatide/legal-status)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Free tools

- [GLP-1 titration calculator](https://pepvault.app/tools/glp1-titration-calculator)
- [Missed a GLP-1 dose?](https://pepvault.app/tools/missed-glp1-dose)
- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Tirzepatide: up to 20.9% weight loss at 72 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2022)
- [Tirzepatide 15 mg: 14.7% weight loss at 72 weeks in SURMOUNT-2](https://pepvault.app/research/tirzepatide-surmount-2-2023)
- [Tirzepatide: AHI fell 25.3 and 29.3 events per hour in SURMOUNT-OSA](https://pepvault.app/research/tirzepatide-surmount-osa-2024)
- [Tirzepatide: 20.2% weight loss vs 13.7% on semaglutide at 72 weeks](https://pepvault.app/research/tirzepatide-surmount-5-2025)
- [Tirzepatide: most reached a weight plateau by week 72 in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-and-surmount-4-2025)
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238)
- [Tirzepatide: up to 17.5% weight loss at 52 weeks in SURMOUNT-CN](https://pepvault.app/research/tirzepatide-surmount-cn-2024)

### Brand against brand

- [Mounjaro vs Zepbound](https://pepvault.app/drugs/compare/mounjaro-vs-zepbound)
- [Wegovy vs Zepbound](https://pepvault.app/drugs/compare/wegovy-vs-zepbound)
- [Ozempic vs Zepbound](https://pepvault.app/drugs/compare/ozempic-vs-zepbound)

### Compound against compound

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [CagriSema vs Tirzepatide](https://pepvault.app/peptides/compare/cagrisema-vs-tirzepatide)
- [Tirzepatide vs Eloralintide](https://pepvault.app/peptides/compare/tirzepatide-vs-eloralintide)
- [Tirzepatide vs VK2735](https://pepvault.app/peptides/compare/tirzepatide-vs-vk2735)
- [Tirzepatide vs Enicepatide](https://pepvault.app/peptides/compare/tirzepatide-vs-enicepatide)

## Questions about Zepbound

### What is the Zepbound dosing schedule?

The label starts at 2.5 mg once a week for 4 weeks, then 5 mg. The dose may rise in 2.5 mg steps after at least 4 weeks on each, up to 15 mg. A prescriber sets the schedule.

### What is the maintenance dose of Zepbound?

For weight, 5 mg, 10 mg or 15 mg once a week. For obstructive sleep apnea, 10 mg or 15 mg. The 2.5 mg dose is not approved as a lasting dose.

### What if I miss a Zepbound dose?

The label says to take it as soon as possible within 4 days (96 hours); after more than 4 days, skip it and take the next one on the usual day.

### How long can Zepbound be out of the fridge?

A single-dose pen or vial can be unrefrigerated, at no more than 86°F, for up to 21 days in total. An unopened KwikPen or multi-dose vial at room temperature is thrown away after 30 days.

### What is Zepbound approved for?

Reducing excess weight and keeping it off in adults with obesity, or with overweight and a weight-related condition, and treating moderate to severe obstructive sleep apnea in adults with obesity.

## Sources

- [ZEPBOUND (tirzepatide) injection, for subcutaneous use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b) (version 40, published Sep 2, 2026; read Nov 18, 2026)
- [Drugs@FDA, NDA 217806](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217806) (Zepbound, the injection; application first approved 2023)

PepVault is not affiliated with Eli Lilly. Zepbound is a trademark of its owner.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on tirzepatide

### Tirzepatide on PepVault

- [Tirzepatide in the peptide library](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide: half-life](https://pepvault.app/peptides/tirzepatide/half-life)
- [Tirzepatide: side effects](https://pepvault.app/peptides/tirzepatide/side-effects)
- [Tirzepatide: how long it takes to work](https://pepvault.app/peptides/tirzepatide/how-long-to-work)
- [Tirzepatide: what it’s stacked with](https://pepvault.app/peptides/tirzepatide/stacks)
- [Is Tirzepatide legal? FDA, DEA and WADA status](https://pepvault.app/peptides/tirzepatide/legal-status)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Free tools

- [GLP-1 titration calculator](https://pepvault.app/tools/glp1-titration-calculator)
- [Missed a GLP-1 dose?](https://pepvault.app/tools/missed-glp1-dose)
- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Tirzepatide: up to 20.9% weight loss at 72 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2022)
- [Tirzepatide 15 mg: 14.7% weight loss at 72 weeks in SURMOUNT-2](https://pepvault.app/research/tirzepatide-surmount-2-2023)
- [Tirzepatide: AHI fell 25.3 and 29.3 events per hour in SURMOUNT-OSA](https://pepvault.app/research/tirzepatide-surmount-osa-2024)
- [Tirzepatide: 20.2% weight loss vs 13.7% on semaglutide at 72 weeks](https://pepvault.app/research/tirzepatide-surmount-5-2025)
- [Tirzepatide: most reached a weight plateau by week 72 in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-and-surmount-4-2025)
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238)
- [Tirzepatide: up to 17.5% weight loss at 52 weeks in SURMOUNT-CN](https://pepvault.app/research/tirzepatide-surmount-cn-2024)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Brand-name drugs

- [Every brand, by ingredient](https://pepvault.app/drugs)
- [Mounjaro](https://pepvault.app/drugs/mounjaro)
- [Mounjaro vs Zepbound](https://pepvault.app/drugs/compare/mounjaro-vs-zepbound)
- [Wegovy vs Zepbound](https://pepvault.app/drugs/compare/wegovy-vs-zepbound)
- [Ozempic vs Zepbound](https://pepvault.app/drugs/compare/ozempic-vs-zepbound)

## The library

- [Tirzepatide in the peptide library](https://pepvault.app/peptides/tirzepatide)
- [The peptide reference library](https://pepvault.app/peptides)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. PepVault is not affiliated with Eli Lilly. Zepbound is a trademark of its owner.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
